Warburg Research set a €153.50 ($178.49) price objective on Sartorius (FRA:SRT3) in a research report sent to investors on Thursday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other equities research analysts also recently weighed in on the stock. Deutsche Bank set a €150.00 ($174.42) target price on shares of Sartorius and gave the stock a neutral rating in a research note on Thursday, April 11th. Hauck & Aufhaeuser set a €130.00 ($151.16) target price on shares of Sartorius and gave the stock a sell rating in a research note on Thursday, April 4th. Berenberg Bank set a €110.00 ($127.91) target price on shares of Sartorius and gave the stock a neutral rating in a research note on Tuesday, January 29th. UBS Group set a €147.00 ($170.93) target price on shares of Sartorius and gave the stock a neutral rating in a research note on Wednesday, February 20th. Finally, Kepler Capital Markets set a €107.00 ($124.42) target price on shares of Sartorius and gave the stock a sell rating in a research note on Tuesday, January 29th. Five research analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. The stock presently has an average rating of Sell and an average target price of €122.89 ($142.89).

Shares of SRT3 opened at €152.90 ($177.79) on Thursday. Sartorius has a fifty-two week low of €71.00 ($82.56) and a fifty-two week high of €124.70 ($145.00).

Sartorius Company Profile

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors.

See Also: What is the yield curve?

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.